Shanghai Sinobioway Sunterra Biotechnology

General

About Company

Shanghai Sinobioway Sunterra Biotechnology is developing novel cellular therapies for solid tumor malignancies in China.

Industry

Sector :

Subsector :

IPO status

Private

Description

The company, founded in Shanghai in 2016 by Wu Zili, sublicenses the CAB-CAR-T technology from F1 Oncology and operates GMP cell processing facilities in Shanghai to support clinical research collaborations.

Contacts

location

Shanghai, China

Phone number

02163916608

Website URL

http://www.sunterra-bio.com/zh-cn/